BIRC2 and MALT lymphoma: The IAP2-MALT1 fusion protein thus seems to drive cellular transformation by multiple means, suggesting that inhibition of the MALT1 protease activity could be an attractive new treatment approach for t(11;18)-positive MALT lymphoma.